BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15757604)

  • 1. Risks of noncardiac surgery after coronary stenting.
    Reddy PR; Vaitkus PT
    Am J Cardiol; 2005 Mar; 95(6):755-7. PubMed ID: 15757604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major noncardiac surgery following coronary stenting: when is it safe to operate?
    Sharma AK; Ajani AE; Hamwi SM; Maniar P; Lakhani SV; Waksman R; Lindsay J
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):141-5. PubMed ID: 15390248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
    Rabbitts JA; Nuttall GA; Brown MJ; Hanson AC; Oliver WC; Holmes DR; Rihal CS
    Anesthesiology; 2008 Oct; 109(4):596-604. PubMed ID: 18813037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiovascular risk of noncardiac surgery following coronary angioplasty with versus without stenting.
    Leibowitz D; Cohen M; Planer D; Mosseri M; Rott D; Lotan C; Weiss AT
    Am J Cardiol; 2006 Apr; 97(8):1188-91. PubMed ID: 16616024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.
    Nuttall GA; Brown MJ; Stombaugh JW; Michon PB; Hathaway MF; Lindeen KC; Hanson AC; Schroeder DR; Oliver WC; Holmes DR; Rihal CS
    Anesthesiology; 2008 Oct; 109(4):588-95. PubMed ID: 18813036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprocedural low molecular weight heparin in patients at high risk of subacute stent thrombosis.
    Daoulah A; Segev A; Leblanc K; Chisholm RJ; Strauss BH
    Cardiovasc Radiat Med; 2003; 4(4):182-5. PubMed ID: 15321055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac outcome of major noncardiac surgery in patients undergoing preoperative coronary angioplasty.
    Jones SE; Raymond RE; Simpfendorfer CC; Whitlow PL
    J Invasive Cardiol; 1993; 5(6):212-8. PubMed ID: 10172010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events.
    Schouten O; van Domburg RT; Bax JJ; de Jaegere PJ; Dunkelgrun M; Feringa HH; Hoeks SE; Poldermans D
    J Am Coll Cardiol; 2007 Jan; 49(1):122-4. PubMed ID: 17207733
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of patients with cardiac stents undergoing noncardiac surgery.
    Schouten O; Bax JJ; Poldermans D
    Curr Opin Anaesthesiol; 2007 Jun; 20(3):274-8. PubMed ID: 17479034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting.
    Brichon PY; Boitet P; Dujon A; Mouroux J; Peillon C; Riquet M; Velly JF; Ris HB
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):793-6. PubMed ID: 16996274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six hour ambulation after elective coronary angioplasty and stenting with 7F guiding catheters ald low dose heparin.
    Tengiz I; Ercan E; Bozdemir H; Durmaz O; Gurgun C; Nalbantgil I
    Kardiol Pol; 2003 Feb; 58(2):93-7. PubMed ID: 14504634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative cardiovascular evaluation for noncardiac surgery.
    Maddox TM
    Mt Sinai J Med; 2005 May; 72(3):185-92. PubMed ID: 15915313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
    Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of noncardiac surgery after coronary drug-eluting stent implantation.
    Compton PA; Zankar AA; Adesanya AO; Banerjee S; Brilakis ES
    Am J Cardiol; 2006 Nov; 98(9):1212-3. PubMed ID: 17056330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.